Investigating how structural racism affects immune responses and genetic mutations related to MGUS in African Americans

Role of Disadvantage, Mutographs and T Cell Immunity on MGUS in African Americans

['FUNDING_R01'] · UNIVERSITY OF ALABAMA AT BIRMINGHAM · NIH-11108602

This study is looking at how racism affects the way certain genetic changes and immune responses work in African Americans who are at risk for a condition called MGUS, which can lead to multiple myeloma, to help find better ways to prevent and treat this health issue.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF ALABAMA AT BIRMINGHAM (nih funded)
Locations1 site (BIRMINGHAM, UNITED STATES)
Trial IDNIH-11108602 on ClinicalTrials.gov

What this research studies

This research aims to understand how structural racism influences the relationship between genetic mutations and T cell immunity in African Americans at risk for monoclonal gammopathy of undetermined significance (MGUS), a precursor to multiple myeloma. By focusing on this population, the study seeks to uncover the environmental and genomic factors that contribute to the higher incidence of MGUS among African Americans. Participants will be evaluated for specific mutational signatures and immune responses, helping to identify the underlying causes of health disparities. The findings could lead to improved prevention and treatment strategies tailored to this demographic.

Who could benefit from this research

Good fit: Ideal candidates for this research are African American individuals who may be at risk for MGUS or have been diagnosed with it.

Not a fit: Patients who are not of African descent or those without a diagnosis or risk factors for MGUS may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of MGUS, ultimately improving outcomes for African American patients at risk for multiple myeloma.

How similar studies have performed: While there has been research on MGUS and multiple myeloma, this specific focus on structural racism and its impact on African American populations is relatively novel.

Where this research is happening

BIRMINGHAM, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.